Document Detail


HIV-Derived Vectors for Gene Therapy Targeting Dendritic Cells.
MedLine Citation:
PMID:  22975878     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Human immunodeficiency virus type 1 (HIV-1)-derived lentiviral vectors (LV) have the potential to mediate stable therapeutic gene transfer. However, similarly to other viral vectors, their benefit is compromised by the induction of an immune response toward transgene-expressing cells that closely mimics antiviral immunity. LV share with the parental HIV the ability to activate dendritic cells (DC), while lack the peculiar ability of subverting DC functions, which is responsible for HIV immune escape. Understanding the interaction between LV and DC, with plasmacytoid and myeloid DC playing fundamental and distinct roles, has paved the way to novel approaches aimed at regulating transgene-specific immune responses. Thanks to the ability to target either DC subsets LV might be a powerful tool to induce immunity (i.e., gene therapy of cancer), cell death (i.e., in HIV/AIDS infection), or tolerance (i.e., gene therapy strategies for monogenic diseases). In this chapter, similarities and differences between the LV-mediated and HIV-mediated induction of immune responses, with specific focus on their interactions with DC, are discussed.
Authors:
Maura Rossetti; Mariangela Cavarelli; Silvia Gregori; Gabriella Scarlatti
Related Documents :
22997518 - Viral infection: an evolving insight into the signal transduction pathways responsible ...
24133218 - Pan-mtor inhibitor azd8055 primes rhabdomyosarcoma cells for abt-737-induced apoptosis ...
24833468 - Connexin43 sirna promotes huvec proliferation and inhibits apoptosis induced by ox-ldl:...
23970288 - The novel synthetic compound 6-acetyl-9-(3,4,5-trimetho-xybenzyl)-9h-pyrido[2,3-b]indol...
16778308 - Immune responses in kala-azar.
21994798 - Unconventional use of lc3 by coronaviruses through the alleged subversion of the erad t...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  762     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2013  
Date Detail:
Created Date:  2012-09-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  239-61     Citation Subset:  IM    
Affiliation:
Division of Regenerative Medicine, Stem Cells, and Gene Therapy, San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), San Raffaele Scientific Institute, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  HIV Impairment of Immune Responses in Dendritic Cells.
Next Document:  Targeting Dendritic Cells for Improved HIV-1 Vaccines.